TuHURA Biosciences (HURA) News Today $3.92 +0.00 (+0.13%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period TuHURA Biosciences, Inc. Initiates Phase 1b/2a Study of IFx-Hu2.0 as an Adjunctive Therapy to Keytruda® (pembrolizumab) in First Line Treatment for Metastatic Merkel Cell Carcinoma of Unknown Primary Origin (MCCUP)May 5 at 8:00 AM | prnewswire.comGeode Capital Management LLC Buys New Holdings in TuHURA Biosciences (NASDAQ:HURA)Geode Capital Management LLC bought a new stake in shares of TuHURA Biosciences (NASDAQ:HURA - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 264,915 shares of the company's stock, valued at apMay 3 at 3:20 AM | marketbeat.comTuHURA And Kineta Present Updated Results From Phase I-II Study Of KVA12123April 30, 2025 | nasdaq.comTuHURA Biosciences: Promising Developments in Anti-VISTA Antibody and DNA-based Immune Activator Justify Buy RatingApril 29, 2025 | tipranks.comTuHURA Biosciences and Kineta Present Updated Results from Kineta's Phase I-II Study of KVA12123 and TuHURA's Mechanism of IFx-Hu2.0 Responses After Anti-PD-1 Therapy Failure ...April 29, 2025 | seekingalpha.comTuHURA Biosciences and Kineta Present Updated Results from Kineta's Phase I-II Study of KVA12123 and TuHURA's Mechanism of IFx-Hu2.0 Responses After Anti-PD-1 Therapy Failure in Advanced Melanoma at the American Association for Cancer Research Annual MeetingApril 28, 2025 | prnewswire.comIs TuHURA Biosciences, Inc. (HURA) the Best Rising Penny Stock to Buy According to Analysts?April 18, 2025 | insidermonkey.comZacks Small Cap Issues Positive Forecast for HURA EarningsTuHURA Biosciences (NASDAQ:HURA - Free Report) - Equities research analysts at Zacks Small Cap increased their Q3 2025 earnings estimates for TuHURA Biosciences in a research report issued to clients and investors on Monday, April 14th. Zacks Small Cap analyst J. Vandermosten now expects that theApril 18, 2025 | marketbeat.comHURA: 2024 Financial ResultsApril 14, 2025 | msn.comTuHURA Biosciences hires new EVP for drug developmentApril 9, 2025 | uk.investing.comTuHURA Biosciences, Inc. Announces Abstracts Accepted for Poster Presentation at the 2025 AACR Annual MeetingApril 8, 2025 | prnewswire.comQ2 EPS Estimate for TuHURA Biosciences Increased by AnalystTuHURA Biosciences (NASDAQ:HURA - Free Report) - Stock analysts at HC Wainwright upped their Q2 2026 earnings per share (EPS) estimates for TuHURA Biosciences in a research note issued on Thursday, April 3rd. HC Wainwright analyst R. Burns now anticipates that the company will post earnings per sApril 8, 2025 | marketbeat.comTuHURA Biosciences, Inc. Appoints Dr. Bertrand Le Bourdonnec as Executive Vice President, Head of Drug Discovery, Early Development, and Program ManagementApril 7, 2025 | prnewswire.comEquities Analysts Set Expectations for HURA Q3 EarningsTuHURA Biosciences (NASDAQ:HURA - Free Report) - Equities research analysts at HC Wainwright issued their Q3 2026 earnings per share (EPS) estimates for TuHURA Biosciences in a report issued on Thursday, April 3rd. HC Wainwright analyst R. Burns forecasts that the company will earn ($0.10) per shApril 6, 2025 | marketbeat.comHC Wainwright Cuts TuHURA Biosciences (NASDAQ:HURA) Price Target to $12.00HC Wainwright cut their price objective on shares of TuHURA Biosciences from $13.00 to $12.00 and set a "buy" rating for the company in a report on Thursday.April 5, 2025 | marketbeat.comIs TuHURA Biosciences (NASDAQ:HURA) In A Good Position To Deliver On Growth Plans?April 2, 2025 | finance.yahoo.comTuHURA Biosciences, Inc. Reports Financial Results for Fiscal Year 2024 and Provides Corporate UpdateApril 1, 2025 | prnewswire.comTuHURA Biosciences (NASDAQ:HURA) Stock Price Up 1.7% - Still a Buy?TuHURA Biosciences (NASDAQ:HURA) Shares Up 1.7% - Should You Buy?March 28, 2025 | marketbeat.comTuHURA Biosciences Announces Acquisition of Kineta, Inc.March 18, 2025 | msn.comTuHURA Biosciences appoints Craig Tendler to board of directorsMarch 11, 2025 | markets.businessinsider.comTuHURA Biosciences, Inc. to Present at the 37th Annual ROTH ConferenceMarch 10, 2025 | gurufocus.comQ2 Earnings Estimate for HURA Issued By HC WainwrightTuHURA Biosciences (NASDAQ:HURA - Free Report) - Equities researchers at HC Wainwright issued their Q2 2025 earnings per share estimates for shares of TuHURA Biosciences in a report issued on Monday, March 3rd. HC Wainwright analyst R. Burns expects that the company will earn ($0.20) per share foMarch 7, 2025 | marketbeat.comTuHURA Biosciences initiated with a Buy at H.C. WainwrightMarch 4, 2025 | markets.businessinsider.comHC Wainwright & Co. Initiates Coverage of TuHURA Biosciences (HURA) with Buy RecommendationMarch 4, 2025 | msn.comTuHURA Biosciences (NASDAQ:HURA) Earns Buy Rating from Analysts at HC WainwrightHC Wainwright began coverage on TuHURA Biosciences in a report on Monday. They set a "buy" rating and a $13.00 price objective for the company.March 3, 2025 | marketbeat.comSuncoast Equity Management Buys Shares of 102,997 TuHURA Biosciences (NASDAQ:HURA)Suncoast Equity Management purchased a new position in TuHURA Biosciences (NASDAQ:HURA - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 102,997 shares of the company's stock,February 22, 2025 | marketbeat.comTuHURA Biosciences (HURA) to Release Earnings on WednesdayTuHURA Biosciences (NASDAQ:HURA) will be releasing earnings before the market opens on Wednesday, February 26, Financial Modeling Prep reports.February 21, 2025 | marketbeat.comTuHURA Biosciences: A Hold On Only The Faintest Glimmers Of EfficacyFebruary 16, 2025 | seekingalpha.comApollon Wealth Management LLC Acquires New Stake in TuHURA Biosciences (NASDAQ:HURA)Apollon Wealth Management LLC acquired a new stake in shares of TuHURA Biosciences (NASDAQ:HURA - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 61,772 shares of the company's stock, valued at approximately $253,000. ApolloFebruary 15, 2025 | marketbeat.comQ2 Earnings Estimate for HURA Issued By Zacks Small CapTuHURA Biosciences (NASDAQ:HURA - Free Report) - Analysts at Zacks Small Cap issued their Q2 2025 earnings estimates for TuHURA Biosciences in a report released on Tuesday, February 4th. Zacks Small Cap analyst J. Vandermosten anticipates that the company will post earnings of ($0.09) per share fFebruary 5, 2025 | marketbeat.comHURA: Initiating an Immune ResponseFebruary 5, 2025 | msn.comTuHURA Biosciences (HURA) Projected to Post Quarterly Earnings on WednesdayTuHURA Biosciences (NASDAQ:HURA) will be releasing earnings before the market opens on Wednesday, February 12, Financial Modeling Prep reports.February 5, 2025 | marketbeat.comTuHURA Biosciences (NASDAQ:HURA) Trading Down 2.6% - Here's What HappenedTuHURA Biosciences (NASDAQ:HURA) Trading Down 2.6% - What's Next?January 31, 2025 | marketbeat.comWhen Can We Expect A Profit From TuHURA Biosciences, Inc. (NASDAQ:HURA)?January 18, 2025 | uk.finance.yahoo.comRep. Laurel M. Lee Buys TuHURA Biosciences (NASDAQ:HURA) SharesRepresentative Laurel M. Lee (R-Florida) recently bought shares of TuHURA Biosciences (NASDAQ:HURA). In a filing disclosed on January 07th, the Representative disclosed that they had bought between $1,001 and $15,000 in TuHURA Biosciences stock on November 25th. Representative Laurel M. Lee also reJanuary 9, 2025 | marketbeat.comTuHURA Biosciences Inc HURAJanuary 2, 2025 | morningstar.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VTS and HURA on Behalf of ShareholdersDecember 20, 2024 | globenewswire.comTuHURA Biosciences (NASDAQ:HURA) Rating Increased to Strong-Buy at RODMAN&RENSHAWRODMAN&RENSHAW upgraded shares of TuHURA Biosciences to a "strong-buy" rating in a research note on Thursday.December 20, 2024 | marketbeat.comRodman & Renshaw Begins Coverage on TuHURA Biosciences (NASDAQ:HURA)Rodman & Renshaw assumed coverage on TuHURA Biosciences in a research note on Thursday. They set a "buy" rating and a $11.00 target price for the company.December 19, 2024 | marketbeat.comTuHURA Biosciences initiated with a Buy at Rodman & RenshawDecember 18, 2024 | tipranks.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating TuHURA Biosciences, Inc. MergerDecember 13, 2024 | markets.businessinsider.comTuHURA Biosciences to Acquire Kineta, Inc. in 2025December 13, 2024 | markets.businessinsider.comTuHURA Biosciences enters definitive merger agreement to acquire KinetaDecember 12, 2024 | markets.businessinsider.comKineta Merges with TuHURA to Enhance Cancer TreatmentDecember 12, 2024 | markets.businessinsider.comHURA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of TuHURA Biosciences, Inc. Is Fair to ShareholdersDecember 12, 2024 | tmcnet.comSHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of TuHURA Biosciences, Inc. - HURADecember 12, 2024 | prnewswire.comTuHURA Biosciences to acquire KinetaDecember 12, 2024 | seekingalpha.comTuhura Biosciences Inc Share Price (HURA.US)December 7, 2024 | lse.co.ukTuHURA Biosciences Advances in Cancer Immunotherapy InnovationsNovember 25, 2024 | tipranks.comTuHURA Biosciences outlines development pathway for IFx-2.0November 25, 2024 | tipranks.com Get TuHURA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HURA and its competitors with MarketBeat's FREE daily newsletter. Email Address HURA Media Mentions By Week HURA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HURA News Sentiment▼0.340.72▲Average Medical News Sentiment HURA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HURA Articles This Week▼52▲HURA Articles Average Week Get TuHURA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HURA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies XERS News Today DNTH News Today ANAB News Today KALV News Today ABUS News Today TRVI News Today ARVN News Today CDXC News Today PHAR News Today ORGO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HURA) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TuHURA Biosciences Please log in to your account or sign up in order to add this asset to your watchlist. Share TuHURA Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HURA Stock Free HURA Stock Alerts